Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1007/s10157-013-0847-z
Read article for free, from open access legal sources, via Unpaywall: https://escholarship.org/content/qt7qc1t62d/qt7qc1t62d.pdf?t=nm3je7
References
Articles referenced by this article (45)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
N Engl J Med, (3):238-248 2005
MED: 16034009
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.
Nephrol Dial Transplant, (2):218-223 2000
MED: 10648668
The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.
J Am Soc Nephrol, (5):1027-1036 1999
MED: 10232689
Atherosclerosis in CKD: differences from the general population.
Nat Rev Nephrol, (12):723-735 2010
MED: 20978469
In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.
Kidney Int, (4):437-444 2009
MED: 19471321
Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone.
J Clin Invest, (10):2167-2173 1996
MED: 8636395
Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
Kidney Int, (6):2192-2196 2001
MED: 11380821
Association between serum lipids and survival in hemodialysis patients and impact of race.
J Am Soc Nephrol, (1):293-303 2006
MED: 17167113
Novel cardiovascular risk factors in end-stage renal disease.
J Am Soc Nephrol, S77-80 2004
MED: 14684678
Reverse cholesterol transport pathway in experimental chronic renal failure.
Am J Nephrol, (2):147-154 2009
MED: 19321994
Show 10 more references (10 of 45)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1007/s10157-013-0847-z
Article citations
Low LCAT activity is linked to acute decompensated heart failure and mortality in patients with CKD.
J Lipid Res, 65(9):100624, 20 Aug 2024
Cited by: 1 article | PMID: 39154733 | PMCID: PMC11416249
Effects of Polyphenol-Rich Foods on Lipids and Oxidative Stress Status in Patients with Hyperlipidemia: A Systematic Review of Randomized Controlled Trials.
J Multidiscip Healthc, 17:3167-3179, 08 Jul 2024
Cited by: 0 articles | PMID: 39006877 | PMCID: PMC11245574
Review Free full text in Europe PMC
The Beneficial Effects of Curcumin on Lipids: Possible Effects on Dyslipidemia-induced Cardiovascular Complications.
Curr Med Chem, 31(42):6957-6970, 01 Jan 2024
Cited by: 1 article | PMID: 37424347
Review
Lipoproteins and Their Effects on the Cardiovascular System.
Cureus, 15(11):e48865, 15 Nov 2023
Cited by: 2 articles | PMID: 38106760 | PMCID: PMC10724412
Review Free full text in Europe PMC
Lipid and nutritional profiles of Caribbean patients with chronic kidney disease.
Afr Health Sci, 23(3):645-654, 01 Sep 2023
Cited by: 2 articles | PMID: 38357113 | PMCID: PMC10862584
Go to all (52) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Lipid disorders and their relevance to outcomes in chronic kidney disease.
Blood Purif, 31(1-3):189-196, 10 Jan 2011
Cited by: 69 articles | PMID: 21228589
Review
HDL metabolism and activity in chronic kidney disease.
Nat Rev Nephrol, 6(5):287-296, 23 Mar 2010
Cited by: 86 articles | PMID: 20308998
Review
Causes of dysregulation of lipid metabolism in chronic renal failure.
Semin Dial, 22(6):644-651, 01 Nov 2009
Cited by: 59 articles | PMID: 20017835 | PMCID: PMC2874323
Review Free full text in Europe PMC
Lipotoxicity and impaired high density lipoprotein-mediated reverse cholesterol transport in chronic kidney disease.
J Ren Nutr, 20(5 suppl):S35-43, 01 Sep 2010
Cited by: 54 articles | PMID: 20797569
Review